entertainment -WSS

entertainment

author：hotspot 2025-09-28 23:31:19 - browse：6235

Mathai Mammen crosses his arms and looks into the camera — coverage from STAT — FogPharma CEO Mathai Mammen Boston Globe Photo Import

Oncology startup FogPharma just closed a $145 million Series E round, the company confirmed, reaching a late stage of financing that few other biotechs have hit in recent years.

FogPharma, which is headquartered in Cambridge, Mass., is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells.

As CEO Mathai Mammen sees it, very few exemplary medicines shuttle off of drug companies’ pipelines, wade through clinical trials, and end up in the hands of physicians and patients in a given year. Far more often, pharma and biotech companies are pushing out drugs that are incrementally better than what came before, extending cancer patients’ survival by a few more months, halting their tumor growth for a little while longer. But FogPharma could deliver something truly unique, Mammen said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： VC firm RA Capital starts a new synthetic biology incubator

WSS

Study finds new variant for Parkinson’s in African populations

CDC advisory panel says seniors 'may' get RSV vaccine

VC firm RA Capital starts a new synthetic biology incubator

What do new weight loss drugs mean for bariatric surgery?

How to make AI work for medicine

How to make AI work for medicine

focus

entertainment

focus

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Medicare explains how it will choose drugs for negotiation

Peter Hotez and the public health issue of online harassment

Interest rates are at a 22

The high cost of giving birth even with insurance

Biden announces an advanced cancer research initiative

ChatGPT in medicine: STAT answers readers' burning questions

Diversity in medical illustrations gets boost from Chidiebere Ibe

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Complete sequence of Y chromosome published for first time

hotspot

Psilocybin's anti

Neuroscience startup Neumora files for IPO

‘We were in the air.’ Mississippi family recounts surviving tornado that tore mobile home apart

Will biotech layoffs continue through 2023?

Apellis safety probe of eye disease drug centers on injection needle

How Long Island became the ‘eugenics capital of the world’

explore

leisure time

Wikipedia

hotspot